Literature DB >> 17113230

Protection of vincristine-induced neuropathy by WldS expression and the independence of the activity of Nmnat1.

Masashi Watanabe1, Tadasuke Tsukiyama, Shigetsugu Hatakeyama.   

Abstract

The slow Wallerian degeneration protein (WldS), a fusion protein containing amino-terminal E4B and full-length nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1), delays axon degeneration caused by physical damages, toxins and genetic mutations which result in patients being diagnosed with neurodegenerative diseases. It is still controversial whether the suppression of axonal degeneration by WldS is due to Nmnat1 or other portion. We generated WldS or Nmnat1-overexpressing Neuro2A cell lines, in which neuronal differentiation including neurite elongation can be induced by retinoic acid. The overexpression of WldS delayed the neurite degeneration by vincristine, whereas that of Nmnat1 did not delay it much. Taken together, Nmnat1 is considerably weaker than WldS for protection from toxic injury in vitro, suggesting that amino-terminal region of WldS is likely to be more significant for protection from axonal degeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113230     DOI: 10.1016/j.neulet.2006.09.068

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Wld(S), Nmnats and axon degeneration--progress in the past two decades.

Authors:  Yan Feng; Tingting Yan; Zhigang He; Qiwei Zhai
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

Review 2.  Mammalian sirtuins: biological insights and disease relevance.

Authors:  Marcia C Haigis; David A Sinclair
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

3.  Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo.

Authors:  Yo Sasaki; Bhupinder P S Vohra; Robert H Baloh; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2009-05-20       Impact factor: 6.167

Review 4.  NMNATs, evolutionarily conserved neuronal maintenance factors.

Authors:  Yousuf O Ali; David Li-Kroeger; Hugo J Bellen; R Grace Zhai; Hui-Chen Lu
Journal:  Trends Neurosci       Date:  2013-08-20       Impact factor: 13.837

5.  Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila.

Authors:  Andrew Rallis; Bingwei Lu; Julian Ng
Journal:  J Cell Sci       Date:  2012-12-21       Impact factor: 5.285

6.  Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.

Authors:  Thomas M Wishart; Janet M Paterson; Duncan M Short; Sara Meredith; Kevin A Robertson; Calum Sutherland; Michael A Cousin; Mayank B Dutia; Thomas H Gillingwater
Journal:  Mol Cell Proteomics       Date:  2007-04-29       Impact factor: 5.911

7.  Targeting anti-inflammatory treatment can ameliorate injury-induced neuropathic pain.

Authors:  Katsuyuki Iwatsuki; Tetsuya Arai; Hideyuki Ota; Shuichi Kato; Tadahiro Natsume; Shigeru Kurimoto; Michiro Yamamoto; Hitoshi Hirata
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

8.  Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds).

Authors:  Thomas M Wishart; Helen N Pemberton; Sally R James; Chris J McCabe; Thomas H Gillingwater
Journal:  Genome Biol       Date:  2008-06-20       Impact factor: 13.583

9.  Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo.

Authors:  Richard A Slivicki; Yousuf O Ali; Hui-Chen Lu; Andrea G Hohmann
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Heparanase attenuates axon degeneration following sciatic nerve transection.

Authors:  Michael J Whitehead; Rhona McGonigal; Hugh J Willison; Susan C Barnett
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.